You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – With €34 million ($39.9 million) in funding, a European research project was announced on Monday targeting patients most at-risk for non-alcoholic fatty liver disease, or NAFLD.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.